Journal of Nutrition and Health

The Korean Nutrition Society (한국영양학회)
권호 표지

The Presence of Diabetes Mellitus and Anemia in Korean Adults-based on Data from 2005 Korean National Health and Nutrition Examination Survey(KNHANES III)

한국 성인에서 당뇨병이 빈혈의 발생에 미치는 영향 - 2005년 국민건강영양조사 자료를 중심으로

  • Kim, Ji-Hye (Department of food and nutrition, Daegu University)
  • 김지혜 (대구대학교 식품영양학과)
  • Published : 2008.09.30
Download PDF
⟨ Previous Next ⟩

Abstract

Anemia is common in Diabetes Mellitus(DM) with chronic kidney disease. Recent research suggests that DM itself also may be a risk factor of anemia even though kidney failure causes anemia. However, it has not been reported that the impact of DM on anemia in representative data of Korean population. A total of 5,417 Korean adults aged 20 years and older(2,328 men, 3,089 women) were selected from the participants of the 2005 Korean National Health and Nutrition Examination Survey(KNHANES) for this study. Anemia was defined as hemoglobin(Hb) < 13 g/dL and hematocrit(Hct) < 39% for men or Hb < 12 g/dL and Hct < 36% for women. DM was defined as a fasting blood glucose $\geq$ 126 mg/dL. Korean adults with anemia had a higher prevalence of DM than in normal adults(11.4 vs 7.5%; p<0.0001). The unadjusted odds ratio(OR) for anemia was greater in Korean men with DM than in normal men(OR=4.25; 95% CI: 2.48-7.29). This results did not differ after adjustment for the putative risk factors for anemia including chronic disease(OR=2.64; 95% CI: 1.45-4.83). However, the presence of DM was not related with anemia in Korean women. In conclusion, this study revealed that DM might be an independent risk factor for anemia in Korean men. Identification and management for anemia are needed in Korean population with DM as well.

Keywords

References

  1. Abramson JL, Jurkovitz CT, Vaccarino V, Weintraub WS, Mc-Clellan W. Chronic kidney disease, anemia, and incident stroke in a middle-aged, community-based population: the ARIC Study. Kidney Int 2003; 64: 610-615 https://doi.org/10.1046/j.1523-1755.2003.00109.x
  2. Eschbach JW, Kelly MR, Haley NR, Abels RI, Adamson JW. Treatment of the anemia of progressive renal failure with recombinant human erythropoietin. N Engl J Med 1989; 321: 158-163 https://doi.org/10.1056/NEJM198907203210305
  3. McGill JB, Bell DS. Anemia and the role of erythropoietin in diabetes. J Diabetes Complications 2006; 20: 262-272 https://doi.org/10.1016/j.jdiacomp.2005.08.001
  4. Virani SA, Khosla A, Levin A. Chronic kidney disease, heart failure and anemia. Can J Cardiol 2008; 24: 22B-24B https://doi.org/10.1016/S0828-282X(08)71026-2
  5. Astor BC, Muntner P, Levin A, Eustace JA, Coresh J. Association of kidney function with anemia: the Third National Health and Nutrition Examination Survey (1988-1994). Arch Intern Med 2002; 162: 1401-1408 https://doi.org/10.1001/archinte.162.12.1401
  6. Bosman DR, Winkler AS, Marsden JT, Macdougall IC, Watkins PJ. Anemia with erythropoietin deficiency occurs early in diabetic nephropathy. Diabetes Care 2001; 24: 495-499 https://doi.org/10.2337/diacare.24.3.495
  7. Ishimura E, Nishizawa Y, Okuno S, Matsumoto N, Emoto M, Inaba M, Kawagishi T, Kim CW, Morii H. Diabetes mellitus increases the severity of anemia in non-dialyzed patients with renal failure. J Nephrol 1998; 11: 83-86
  8. Valderrabano F. Anaemia management in chronic kidney disease patients: an overview of current clinical practice. Nephrol Dial Transplant 2002; 17 Suppl 1: 13-18
  9. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med 2005; 352: 1011-1023 https://doi.org/10.1056/NEJMra041809
  10. Holland DC, Lam M. Predictors of hospitalization and death among pre-dialysis patients: a retrospective cohort study. Nephrol Dial Transplant 2000; 15: 650-658 https://doi.org/10.1093/ndt/15.5.650
  11. Thomas MC, MacIsaac RJ, Tsalamandris C, et al. Anemia in patients with type 1 diabetes. J Clin Endocrinol Metab 2004; 89: 4359-4363 https://doi.org/10.1210/jc.2004-0678
  12. Ueda H, Ishimura E, Shoji T, et al. Factors affecting progression of renal failure in patients with type 2 diabetes. Diabetes Care 2003; 26: 1530-1534 https://doi.org/10.2337/diacare.26.5.1530
  13. Kim DH, Kim TY, Kim SM, Yoo SJ, Oh DJ, SH Y. IGF-1 is an Independent Risk Factor for Anemia in Diabetic Pre-dialysis Patients. Korean J Intern Med 2007; 22(3): 186-191 https://doi.org/10.3904/kjim.2007.22.3.186
  14. World Health Organization/UNICEF/UNU. Iron deficiency anemia assessment, prevention and control: A guide for programme managers; 2001
  15. The expert committee on the diagnosis and classification of diabetes mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003; 26 Suppl 1: S5-20 https://doi.org/10.2337/diacare.26.2007.S5
  16. Thomas MC, MacIsaac RJ, Tsalamandris C, Power D, Jerums G. Unrecognized anemia in patients with diabetes: a cross-sectional survey. Diabetes Care 2003; 26: 1164-1169 https://doi.org/10.2337/diacare.26.4.1164
  17. Dikow R, Schwenger V, Schomig M, Ritz E. How should we manage anaemia in patients with diabetes? Nephrol Dial Transplant 2002; 17 Suppl 1: 67-72
  18. Ritz E. Managing anaemia and diabetes: a future challenge for nephrologists. Nephrol Dial Transplant 2005; 20 Suppl 6: vi21-5 https://doi.org/10.1093/ndt/gfh1093
  19. Ritz E, Haxsen V. Diabetic nephropathy and anaemia. Eur J Clin Invest 2005; 35 Suppl 3: 66-74 https://doi.org/10.1111/j.1365-2362.2005.01544.x
  20. Thomas S, Rampersad M. Anaemia in diabetes. Acta Diabetol 2004; 41 Suppl 1: S13-17 https://doi.org/10.1007/s00592-004-0132-4
  21. Khoshdel A, Carney S, Gillies A, Mourad A, Jones B, Nanra R, Trevillian P. Potential roles of erythropoietin in the management of anaemia and other complications diabetes. Diabetes Obes Metab 2008; 10: 1-9
  22. Yun YS, Lee HC, Yoo NC, Song YD, Lim SK, Kim KR, Hahn JS, Huh KB. Reduced erythropoietin responsiveness to anemia in diabetic patients before advanced diabetic nephropathy. Diabetes Res Clin Pract 1999; 46: 223-229 https://doi.org/10.1016/S0168-8227(99)00097-2
  23. Ahn SH, Garewal HS. Low erythropoietin level can cause anemia in patients without advanced renal failure. Am J Med 2004; 116: 280-281 https://doi.org/10.1016/j.amjmed.2003.09.047
  24. Kim DJ, Kim YM, Yun YS, Ahn CW, Cha BS, Song YD, Lim SK, Kim KR, Hahn JS, Huh KB, Lee HC. Therapeutic effect of recombinant human erythropoietin on anaemia with erythropoietin deficiency in diabetic patients. Diabet Med 2003; 20: 661-664 https://doi.org/10.1046/j.1464-5491.2003.01012.x
  25. Rarick MU, Espina BM, Colley DT, Chrusoskie A, Gandara S, Feinstein DI. Treatment of a unique anemia in patients with IDDM with epoetin alfa. Diabetes Care 1998; 21: 423-426 https://doi.org/10.2337/diacare.21.3.423
  26. Winkler AS, Marsden J, Chaudhuri KR, Hambley H, Watkins PJ. Erythropoietin depletion and anaemia in diabetes mellitus. Diabet Med 1999; 16: 813-819 https://doi.org/10.1046/j.1464-5491.1999.00172.x
  27. Ozdemir A, Sevinc C, Selamet U, Kamaci B, Atalay S. Age- and body mass index-dependent relationship between correction of iron deficiency anemia and insulin resistance in non-diabetic premenopausal women. Ann Saudi Med 2007; 27: 356-361 https://doi.org/10.4103/0256-4947.51476
  28. Todd T, Caroe T. Newly diagnosed iron deficiency anaemia in a premenopausal woman. BMJ 2007; 334: 259 https://doi.org/10.1136/bmj.39003.602338.94
  29. Ryu ON, Lee SH, Park KW, Kim EK. Nutritional Iron Status in Pre- and Postmenopause Middle-Aged Women in Kangnung Area. J Korean Dietetic Assoc 1999; 5(2): 164-174